Published in Rev Fr Etud Clin Biol on April 01, 1967
An inherited molecular lesion of erythrocyte pyruvate kinase. Identification of a kinetically aberrant isozyme associated with premature hemolysis. J Clin Invest (1968) 1.19
Hereditary hemolytic anemias associated with specific erythrocyte enzymopathies. Calif Med (1968) 0.89
Genetical theory and the "inborn errors of metabolism". Br Med J (1970) 0.86
Hemolytic anemia due to pyruvate kinase deficiency: characterization of the enzymatic activity from eight patients. Am J Hum Genet (1979) 0.81
Genetics and clinical enzymology. J Clin Pathol Suppl (Assoc Clin Pathol) (1970) 0.75
A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer (1981) 4.25
Point mutation in the beta-spectrin gene associated with alpha I/74 hereditary elliptocytosis. Implications for the mechanism of spectrin dimer self-association. J Clin Invest (1990) 1.41
Teleradiology in northern Quebec. Radiology (1981) 1.16
Anomalies of blood group antigens and erythrocyte enzymes in two types of chronic refractory anaemia. Br J Haematol (1969) 1.08
[Criteria for assessing granulocytic or platelet cytopenia caused by drugs. Results of consensus meetings]. Nouv Rev Fr Hematol (1987) 1.04
[Glutathione synthesis during congenital hemolytic anemia with reduced glutathione deficiency. Congenital erythrocytic glutathione-synthetase deficiency?]. Nouv Rev Fr Hematol (1966) 1.04
Immune disorders in agnogenic myeloid metaplasia: relations to myelofibrosis. Br J Haematol (1983) 1.02
Spectrin beta-chain variant associated with hereditary elliptocytosis. J Clin Invest (1982) 1.02
Blood polymorphonuclear dysfunction in patients with alcoholic cirrhosis. Eur J Clin Invest (1977) 1.01
Retinoic acid therapy for promyelocytic leukaemia. Lancet (1989) 1.00
Quantitative iodination of human blood polymorphonuclear leukocytes. Eur J Clin Invest (1975) 0.96
[Hereditary elliptocytosis in West Africa: frequency and repartition of spectrin variants]. C R Acad Sci III (1988) 0.94
Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol (1994) 0.94
Superoxide dismutase, catalase, and glutathione peroxidase in red blood cells from patients with malignant diseases. Cancer Res (1984) 0.93
[Primary biliary cirrhosis and pernicious anemia. A fortuitous association? (author's transl)]. Gastroenterol Clin Biol (1980) 0.93
A new abnormal variant of spectrin in black patients with hereditary elliptocytosis. Blood (1985) 0.92
Post-translational modifications of human glucose-6-phosphate dehydrogenase. Biochimie (1974) 0.91
Metabolic activity of phagocytosing granulocytes in chronic granulocytic leukemia: ultrastructural observation of a degranulation defect. Blood (1977) 0.91
[A new erythroenzymopathy: congenital non-spherocytic hemolytic anemia and hereditary erythrocytic adenylate kinase deficiency]. Presse Med (1971) 0.91
The human red cell acid phosphatase is a phosphotyrosine protein phosphatase which dephosphorylates the membrane protein band 3. Biochem Biophys Res Commun (1986) 0.90
In vitro digestion of spectrin, protein 4.1 and ankyrin by erythrocyte calcium dependent neutral protease (calpain I). Int J Biochem (1990) 0.89
Evidence for structural differences between human glucose-6-phosphate dehydrogenase purified from leukocytes and erythrocytes. Biochem Biophys Res Commun (1977) 0.89
[March hemoglobinuria. One case with erythrocyte glutathione peroxidase deficiency]. Nouv Presse Med (1975) 0.88
Sp alpha I/78: a mutation of the alpha I spectrin domain in a white kindred with HE and HPP phenotypes. Blood (1989) 0.88
Hereditary spherocytosis with spectrin deficiency related to null mutations of the beta-spectrin gene. Blood Cells Mol Dis (1998) 0.88
Epidemiological studies of spectrin mutations related to hereditary elliptocytosis and spectrin polymorphisms in Benin. Br J Haematol (1996) 0.88
Molecular mechanism of glucose-6-phosphate dehydrogenase deficiency. Humangenetik (1974) 0.88
[Secondary and acquired erythrocytic enzymopathies]. Presse Med (1970) 0.86
Studies on the nature of different molecular forms of glucose-6-phosphate dehydrogenase purified from human leukocytes. Biochim Biophys Acta (1976) 0.86
[Glutathion-synthetase deficiency with 5-oxoprolinuria. Two new cases and a review of the literature (author's transl)]. Nouv Presse Med (1978) 0.86
Protein band 3 phosphotyrosyl phosphatase. Purification and characterization. Int J Biochem (1987) 0.86
Purification and structural characterization of LTP1 polypeptides from beer. J Agric Food Chem (2000) 0.86
Human granulocyte 6 phosphogluconate dehydrogenase. Purification by elective elution with NADP+, immunological and kinetic properties. Biochimie (1975) 0.86
Immune adaptive microenvironment profiles in intracerebral and intrasplenic lymphomas share common characteristics. Clin Exp Immunol (2011) 0.84
Double inheritance of an alpha I/65 spectrin variant in a child with homozygous elliptocytosis. Blood (1986) 0.84
Gd(minus)Matam, an African glucose-6-phosphate dehydrogenase variant with enzyme deficiency. Biochemical and immunological properties in various hemopoietic tissues. Clin Chim Acta (1975) 0.84
Influence of free Mg2+ on the kinetics of human erythrocyte phosphofructokinase. Biochimie (1981) 0.83
Studies on the mechanism of NADPH oxidation by the granule fraction isolated from human resting polymorphonuclear blood cells. Biochimie (1976) 0.83
Bilirubin and paranitrophenol glucuronyl transferase activities and ultrastructural aspect of the liver in patients with chronic hemolytic anemias. Biomedicine (1976) 0.83
A splice site mutation of the beta-spectrin gene causing exon skipping in hereditary elliptocytosis associated with a truncated beta-spectrin chain. J Biol Chem (1991) 0.83
Ethnic distribution of allele alpha LELY, a low-expression allele of red-cell spectrin alpha-gene. Br J Haematol (1995) 0.82
A primary immunoblastic T malignant lymphoma of the small bowel, with azurophilic intracytoplasmic granules. A histologic, immunologic, and electron microscopy study. Am J Surg Pathol (1988) 0.82
Gd(--) Abrami: a deficient G-6PD variant with hemizygous expression in blood cells of a woman with primary myelofibrosis. Humangenetik (1975) 0.82
Purification and characterization of a casein kinase from human erythrocyte cytosol. Biochem Biophys Res Commun (1979) 0.82
Molecular defect of spectrin in the family of a child with congenital hemolytic poikilocytic anemia. Pediatr Res (1984) 0.82
[Research on genetic abnormality in the hemolytic form of hereditary elliptocytosis with homozygosity for the spectrin alpha I/74 variant]. C R Acad Sci III (1989) 0.82
Mechanisms of the acquired erythrocyte enzyme deficiencies in blood diseases. Clin Chim Acta (1976) 0.82
Abnormal tryptic peptide from the spectrin alpha-chain resulting from alpha- or beta-chain mutations: two genetically distinct forms of the Sp alpha I/74 variant. Br J Haematol (1990) 0.82
L-type pyruvate kinase from human liver. Purification by double affinity elution, electrofocusing and immunological studies. Biochim Biophys Acta (1976) 0.82
Pyruvate kinase isozymes in man. II. L type and erythrocyte-type isozymes. Electrofocusing and immunologic studies. Hum Genet (1976) 0.82
Purification of erythrocyte protein 4.1 by selective interaction with inositol hexaphosphate. Protein Expr Purif (1992) 0.82
Aging and accuracy of protein synthesis in man: search for inactive enzymatic cross-reacting material in granulocytes of aged people. Gerontology (1976) 0.82
Hereditary elliptocytosis: clinical, morphological and biochemical studies of 38 cases. Nouv Rev Fr Hematol (1986) 0.82
[Various aspects of the physiopathology of the alcoholic liver without cirrhosis]. Rev Int Hepatol (1968) 0.82
[Anemia in cirrhosis. Critical review]. Pathol Biol (Paris) (1970) 0.82
[Polyglobulia and hemangioma of the cerebellum. Report of 2 cases with demonstration of an erythropoietic substance in the tumor and plasma]. Presse Med (1965) 0.82
Pyruvate kinase isozymes in man. I. M type isozymes in adult and foetal tissues, electrofocusing and immunological studies. Hum Genet (1976) 0.81
Causal mechanisms of multiple acquired red cell enzyme defects in a patient with acquired dyserythropoiesis. Blood (1976) 0.81
Molecular basis of clinical and morphological heterogeneity in hereditary elliptocytosis (HE) with spectrin alpha I variants. Br J Haematol (1993) 0.81
Red blood cell enzyme abnormalities in patients treated with chemotherapy. Br J Haematol (1979) 0.81
The characterization of protein 4.1 Presles, a shortened variant of RBC membrane protein 4.1. Blood (1985) 0.81
Immunologic study of the age-related loss of activity of six enzymes in the red cells from newborn infants and adults--evidence for a fetal type of erythrocyte phosphofructokinase. Pediatr Res (1977) 0.81
Partially polymerized erythrocyte actin obtained by affinity chromatography on DNAse sepharose. Comparison with rabbit skeletal muscle actin and role of calcium. Biochem Biophys Res Commun (1978) 0.81
A mutant of human red cell pyruvate kinase with high affinity for phosphoenolpyruvate. Enzyme (1974) 0.81
Elliptocytosis-associated spectrin Rouen (beta 220/218) has a truncated but still phosphorylatable beta chain. Br J Haematol (1992) 0.80
A variant of erythrocyte membrane skeletal protein band 4.1 associated with hereditary elliptocytosis. Blood (1984) 0.80
Acquired erythroenzymopathies in blood disorders: study of 200 cases. Br J Haematol (1975) 0.80
Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPI. Arterioscler Thromb Vasc Biol (1999) 0.80
[Congenital deficiency erythrocyte adenylate-kinase]. Presse Med (1970) 0.80
[Importance and role of imidazole and sulfhydryl groups in the catalytic activity of human erythrocyte glucose-6-phosphate dehydrogenase]. Biochimie (1972) 0.80
A shortened variant of red cell membrane protein 4.1. Blood (1982) 0.80
Compartimentalization of spectrin-phosphorylating enzyme in human erythrocytes. Biochem Biophys Res Commun (1980) 0.80
Decreased red cell enolase activity in a 40-year-old woman with compensated haemolysis. Scand J Haematol (1984) 0.79
A liver-type mutation in a case of pronounced erythrocyte phosphofructokinase deficiency without clinical expression. Biochim Biophys Acta (1983) 0.79
[New variants of erythrocyte glucose-6-phosphate dehydrogenase]. Rev Fr Etud Clin Biol (1968) 0.79